A detailed history of Axxcess Wealth Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 11,811 shares of EW stock, worth $875,431. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,811
Previous 13,759 14.16%
Holding current value
$875,431
Previous $1.27 Million 38.66%
% of portfolio
0.02%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$59.7 - $93.78 $116,295 - $182,683
-1,948 Reduced 14.16%
11,811 $779,000
Q2 2024

Aug 09, 2024

SELL
$84.3 - $94.31 $512,544 - $573,404
-6,080 Reduced 30.65%
13,759 $1.27 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $115,628 - $152,322
1,594 Added 8.74%
19,839 $1.9 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $3.85 Million - $4.85 Million
-62,401 Reduced 77.38%
18,245 $1.39 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $786,535 - $1.06 Million
11,353 Added 16.38%
80,646 $5.59 Million
Q2 2023

Aug 08, 2023

BUY
$81.41 - $94.33 $112,508 - $130,364
1,382 Added 2.04%
69,293 $6.54 Million
Q1 2023

May 03, 2023

BUY
$74.26 - $84.51 $161,144 - $183,386
2,170 Added 3.3%
67,911 $5.62 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $687,371 - $879,996
10,064 Added 18.08%
65,741 $4.9 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $199,994 - $260,500
2,428 Added 4.56%
55,677 $4.6 Million
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $109,595 - $162,518
1,267 Added 2.44%
53,249 $5.06 Million
Q1 2022

Aug 11, 2022

BUY
$101.96 - $128.34 $185,057 - $232,937
1,815 Added 3.62%
51,982 $6.12 Million
Q4 2021

Aug 11, 2022

BUY
$106.37 - $130.68 $5.34 Million - $6.56 Million
50,167 New
50,167 $6.5 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.